Explore more about: Robotic Intervention

FDA approves first-in-human trial for neural-enabled prosthetic hand system developed at FIU.

Researchers have developed nanorobotic agents that can navigate through the bloodstream to administer a drug by targeting the active cancerous cells of tumors.

Scientists have created the first robotically driven experimentation system to determine the effects of a large number of drugs on many proteins.